FDA Inspection
Pharmadax (Foshan) Co., Ltd.Pharmadax (Foshan) Co., Ltd. – FDA Inspection, Dec 7, 2024
Record Details
This FDA Inspection record concerns Pharmadax (Foshan) Co., Ltd., with an inspection on December 7, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · ecbc69f9-0b74-4b92-8adf-69f03fedd9c1
Inspection Facts
- Inspection number
- 1258271
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Pharmadax (Foshan) Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmadax (Foshan) Co., Ltd.
- FDA Inspection 1105491 - 2019-09-12
- FDA Inspection 989069 - 2016-09-23
- FDA Inspection 843627 - 2013-07-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.